Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of GAUDIUMIVF
Quarter-by-quarter operating performance
| Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 14.42 | 26.92 | 31.73 | 24.51 | 30.35 |
| Expenses + | 8.76 | 18.20 | 17.96 | 17.95 | 18.18 |
| Operating Profit | 5.66 | 8.72 | 13.77 | 6.56 | 12.17 |
| OPM % | 39.25% | 32.39% | 43.40% | 26.76% | 40.10% |
| Other Income + | 0.00 | 0.23 | 0.15 | 0.10 | 0.18 |
| Interest | 0.39 | 0.43 | 0.51 | 1.20 | 1.29 |
| Depreciation | 0.58 | 0.36 | 0.61 | 0.49 | 0.64 |
| Profit before tax | 4.69 | 8.16 | 12.80 | 4.97 | 10.42 |
| Tax % | 27.72% | 20.96% | 26.64% | 26.96% | 19.77% |
| Net Profit + | 3.40 | 6.46 | 9.38 | 3.63 | 8.36 |
| EPS in Rs | 0.55 | 1.05 | 1.53 | 0.59 | 1.15 |
Financials of GAUDIUMIVF
Annual income statement trend
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 37 | 44 | 48 | 71 | 104 |
| Expenses + | 23 | 24 | 28 | 42 | 67 |
| Operating Profit | 14 | 20 | 19 | 29 | 38 |
| OPM % | 37% | 46% | 41% | 41% | 36% |
| Other Income + | 0 | 0 | 0 | 0 | 1 |
| Interest | 1 | 0 | 1 | 2 | 3 |
| Depreciation | 1 | 1 | 2 | 2 | 3 |
| Profit before tax | 12 | 18 | 17 | 25 | 32 |
| Tax % | 26% | 26% | 38% | 25% | 24% |
| Net Profit + | 9 | 14 | 10 | 19 | 24 |
| EPS in Rs | 89.17 | 136.54 | 104.22 | 3.12 | 3.36 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Financials of GAUDIUMIVF
Capital structure and asset base
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.99 | 0.99 | 0.99 | 31 | 36 |
| Reserves | 8 | 22 | 26 | 16 | 116 |
| Borrowings + | 6 | 12 | 17 | 21 | 25 |
| Other Liabilities + | 3 | 2 | 7 | 22 | 16 |
| Total Liabilities | 18 | 37 | 51 | 89 | 193 |
| Fixed Assets + | 4 | 18 | 19 | 18 | 30 |
| CWIP | 0 | 0 | 0 | 7 | 0 |
| Investments | 0 | 0 | 0 | 5 | 5 |
| Other Assets + | 14 | 18 | 32 | 58 | 158 |
| Total Assets | 18 | 37 | 51 | 89 | 193 |
Financials of GAUDIUMIVF
Operating, investing and financing cash movement
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | -1 | 24 | 3 | 9 | |
| Cash from Investing Activity + | -1 | -16 | -5 | -15 | |
| Cash from Financing Activity + | 3 | 5 | -1 | 2 | |
| Net Cash Flow | 0 | 13 | -3 | -5 | |
| Free Cash Flow | -2 | 9 | 1 | -0 | |
| CFO/OP | 13% | 141% | 27% | 46% |
Financials of GAUDIUMIVF
Working capital efficiency and return ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 65 | 8 | 104 | 170 | 187 |
| Inventory Days | 29 | 111 | 168 | 175 | 38 |
| Days Payable | 114 | 77 | 62 | 338 | 133 |
| Cash Conversion Cycle | -20 | 41 | 210 | 7 | 92 |
| Working Capital Days | 61 | -52 | -15 | 44 | 91 |
| ROCE % | 76% | 45% | 49% | 29% |
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…
Shalby MedTech showed strong revenue growth: ₹47 crores in Q1 FY27, a 53% YoY increase. Key concall takeaways from Shalby Ltd's Q1 FY27 earnings call — and how…